Century Therapeutics
Century Therapeutics is seeking a self-motivated Engineer to develop, characterize, and support next-generation iPSC-derived cell therapies for autoimmune diseases and cancer. The role involves culturing and differentiating stem cells, designing bioreactor studies, and analyzing data to drive process improvements. This position requires extensive collaboration with internal and external teams to advance clinical manufacturing readiness.
Century Therapeutics is a biotechnology company building an allogeneic, iPSC-derived cell therapy platform targeting autoimmune diseases, including type 1 diabetes, and cancer. The company leverages the self-renewing capacity of induced pluripotent stem cells (iPSCs) combined with advanced cellular engineering and manufacturing technologies to develop fit-for-purpose cell therapies. Century is listed on NASDAQ under the ticker IPSC and is headquartered in Philadelphia.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Century Therapeutics.
70% above the average for this role